Literature DB >> 1409590

Emr, an Escherichia coli locus for multidrug resistance.

O Lomovskaya1, K Lewis.   

Abstract

An Escherichia coli chromosomal DNA fragment cloned on a multicopy plasmid conferred resistance to carbonylcyanide m-chlorophenylhydrazone, nalidixic acid, and a number of other toxic compounds. The sequence of the cloned emr locus located at minute 57.5 of the chromosome revealed two open reading frames, emrA and emrB. emrB encodes a highly hydrophobic 56.2-kDa peptide, with 14 potential alpha-helices to span the inner membrane. The peptide is homologous to QacA, a multidrug-resistant pump from Staphylococcus aureus, and belongs to a gene family that includes tetracycline-resistant pumps of Gram-positive bacteria and the galactose/H+ symporter of E. coli. emrA encodes a putative 42.7-kDa peptide containing a single hydrophobic domain and a large C-terminal hydrophilic domain. An active pho-fusion to the C domain suggested that EmrA is a membrane protein. Disruption of emrB significantly increased sensitivity of cells to uncouplers. The cellular content of uncoupler increased in the order: overexpressed emrB cells greater than wild type greater than emrB-.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409590      PMCID: PMC50039          DOI: 10.1073/pnas.89.19.8938

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Active efflux mechanisms for antimicrobial resistance.

Authors:  S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

2.  Efflux-mediated antiseptic resistance gene qacA from Staphylococcus aureus: common ancestry with tetracycline- and sugar-transport proteins.

Authors:  D A Rouch; D S Cram; D DiBerardino; T G Littlejohn; R A Skurray
Journal:  Mol Microbiol       Date:  1990-12       Impact factor: 3.501

3.  Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system.

Authors:  A A Neyfakh; V E Bidnenko; L B Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 4.  Uses of transposons with emphasis on Tn10.

Authors:  N Kleckner; J Bender; S Gottesman
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

5.  Isolation and partial characterization of membrane vesicles carrying markers of the membrane adhesion sites.

Authors:  M H Bayer; G P Costello; M E Bayer
Journal:  J Bacteriol       Date:  1982-02       Impact factor: 3.490

6.  Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones.

Authors:  H Yoshida; M Bogaki; S Nakamura; K Ubukata; M Konno
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

7.  Regulation of ompF porin expression by salicylate in Escherichia coli.

Authors:  J L Rosner; T J Chai; J Foulds
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

8.  A staphylococcal multidrug resistance gene product is a member of a new protein family.

Authors:  L Grinius; G Dreguniene; E B Goldberg; C H Liao; S J Projan
Journal:  Plasmid       Date:  1992-03       Impact factor: 3.466

9.  mprA, an Escherichia coli gene that reduces growth-phase-dependent synthesis of microcins B17 and C7 and blocks osmoinduction of proU when cloned on a high-copy-number plasmid.

Authors:  I del Castillo; J M Gómez; F Moreno
Journal:  J Bacteriol       Date:  1990-01       Impact factor: 3.490

10.  Metal-tetracycline/H+ antiporter of Escherichia coli encoded by a transposon, Tn10. The role of the conserved dipeptide, Ser65-Asp66, in tetracycline transport.

Authors:  A Yamaguchi; N Ono; T Akasaka; T Noumi; T Sawai
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

View more
  158 in total

1.  Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes.

Authors:  M C Sulavik; C Houseweart; C Cramer; N Jiwani; N Murgolo; J Greene; B DiDomenico; K J Shaw; G H Miller; R Hare; G Shimer
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 2.  Riddle of biofilm resistance.

Authors:  K Lewis
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  Purification and ligand binding of EmrR, a regulator of a multidrug transporter.

Authors:  A Brooun; J J Tomashek; K Lewis
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

Review 4.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

5.  EvgA of the two-component signal transduction system modulates production of the yhiUV multidrug transporter in Escherichia coli.

Authors:  Kunihiko Nishino; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

6.  Carboxy-terminal region involved in activity of Escherichia coli TolC.

Authors:  H Yamanaka; H Izawa; K Okamoto
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

7.  The EmrR protein represses the Escherichia coli emrRAB multidrug resistance operon by directly binding to its promoter region.

Authors:  A Xiong; A Gottman; C Park; M Baetens; S Pandza; A Matin
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 8.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis.

Authors:  H Bolhuis; D Molenaar; G Poelarends; H W van Veen; B Poolman; A J Driessen; W N Konings
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

10.  The role of fnx1, a fission yeast multidrug resistance protein, in the transition of cells to a quiescent G0 state.

Authors:  K Dimitrov; S Sazer
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.